When building a cell therapy manufacturing facility, having a defined CQV (Commissioning, Qualification, and Validation) strategy is critical to project success. In this webinar co-sponsored by Precision ADVANCE and Project Farma, our panel of industry experts discuss tips for delivering efficient, reliable, GMP-compliant facilities and processes specific to cell therapy.

(more…)

Scaling up a gene therapy manufacturing facility is extremely complex and challenging. In this webinar, co-sponsored by Precision ADVANCE and Project Farma, a panel of industry experts discuss the strategies and challenges faced when building a cutting-edge gene therapy facility from the planning stages to build-out to operational readiness. They will also share key insights into their company’s approach to building these facilities and for mitigating risk under accelerated timelines.

(more…)

How can stakeholders come together to address cell and gene therapy’s global talent gap? Do we have the right skills and capabilities in place to identify and develop the next generation of ATMPs?

(more…)

Congratulations to Precision’s Mark Clein on moderating a well attended panel at at HLTH Boston 2021. Did you miss “Driving Diversity in Clinical Trials,” where life sciences leaders discussed what they are doing to ensure diversity is deeply ingrained into the planning and execution of all clinical trials, leaving bias in the past?

(more…)

Attending the Cowen Inc. 10th Annual MedTools Conference this week? Project Farma (PF) EVP, John Khoury will be joining a panel of industry experts to speak on “Exploring the Complexities of Cell and Gene Therapy Development and Commercialization” Thursday, October 7, 10:10 – 11:05 AM ET.

(more…)